H
WST icon

Hexavest’s West Pharmaceutical WST Stock Holding History

Hexavest’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$4.12M Sell
9,709
-1,006
-9% -$424K 0.25% 130
2021
Q2 		$3.85M Sell
10,715
-1,827
-15% -$604K 0.19% 143
2021
Q1 		$3.53M Sell
12,542
-3,292
-21% -$942K 0.16% 156
2020
Q4 		$4.49M Sell
15,834
-8,948
-36% -$2.51M 0.17% 145
2020
Q3 		$6.81M Sell
24,782
-1,847
-7% -$489K 0.18% 140
2020
Q2 		$6.05M Buy
26,629
+26,560
+38,493% +$5.22M 0.14% 156
2020
Q1 		$11K Buy
+69
New +$10.6K ﹤0.01% 385

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hexavest's WST Position: Q3 2021 in Review

Hexavest reduced its West Pharmaceutical (WST) stake by 9.4% in Q3 2021, selling an estimated $424K and leaving 9,709 shares worth $4.12M. The position accounts for 0.25% of the portfolio, ranked #130.

Hexavest first reported a position in WST in Q1 2020 and has held it in 7 quarters since. The position peaked at $6.81M in Q3 2020. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Hexavest held 9,709 shares of West Pharmaceutical worth $4.12M as of Q3 2021.
  • Hexavest sold 1,006 West Pharmaceutical shares in Q3 2021, an estimated $424K.
  • West Pharmaceutical made up 0.25% of Hexavest's portfolio in Q3 2021, its #130 holding.
  • Hexavest first reported a position in West Pharmaceutical in Q1 2020 and has held it in 7 quarters since.
  • Hexavest's West Pharmaceutical position peaked at $6.81M in Q3 2020.
  • 670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.